Group One Trading, L.P. Opti Nose, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.76 - $3.82 $21,472 - $46,604	-12,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.77 - $2.93 $21,063 - $34,867	11,900 Added 3966.67%	12,200 $30,000
Q4 2021 Feb 11, 2022	SELL	$1.55 - $3.1 $310 - $620	-200 Reduced 40.0%	300 $0
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.16 $1,175 - $1,580	500 New	500 $2,000

52.9M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $500M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.